AI in Clinical Trials Global Market Report 2025

Global AI In Clinical Trials Market Report 2024

AI In Clinical Trials Global Market Report 2025 – By Offering (Software, Services), By Process (Trial Design, Patient Selection, Site Selection, Patient Monitoring), By Technology (Machine Learning, Deep Learning, Supervised Learning, Other Technologies), By Application (Oncology, Neurological Diseases And Condition, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases, Immunology diseases, Other Applications), By End-User (Pharmaceuticals And Biotechnology Companies, Contract Research Organizations, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

Name: AI in Clinical Trials Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

AI in Clinical Trials Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

AI in Clinical Trials Global Market Report 2025

Proud Members Of

AI In Clinical Trials Market Definition

AI in clinical trials refers to the application of artificial intelligence (AI) technologies and techniques in the planning, design, execution, and analysis of clinical trials. Clinical trials are rigorous research studies that evaluate the safety and effectiveness of medical interventions, such as new drugs, medical devices, or treatment protocols, in human subjects.

The main offerings for AI in clinical trials are software and services. AI in clinical trial services refers to the services that are used to investigate and generate insight from past and current clinical trials. The various processes include trial design, patient selection, site selection, and patient monitoring with various technologies such as Machine Learning, deep learning, supervised learning, other machine learning technologies, and others. These are applied in various applications such as oncology, neurological diseases and condition, cardiovascular diseases, metabolic diseases, infectious diseases, and immunology diseases, and are used by various end-users such as pharmaceuticals and biotechnology companies, contract research organizations, and others.

AI In Clinical Trials Market Segmentation

The AI in clinical trials market covered in this report is segmented –

1) By Offering: Software, Services

2) By Process: Trial Design, Patient Selection, Site Selection, Patient Monitoring

3) By Technology: Machine Learning, Deep Learning, Supervised Learning, Other Technologies

4) By Application: Oncology, Neurological Diseases And Condition, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases, Immunology Diseases, Other Applications

5) By End-User: Pharmaceuticals And Biotechnology Companies, Contract Research Organizations, Other End-Users

Subsegments:

1) By Software: Clinical Trial Management Systems (CTMS), Data Analytics Software, Predictive Analytics Tools, Patient Recruitment And Retention Software, Real-World Evidence Platforms

2) By Services: Consulting Services, Data Management And Analysis Services, Training And Support Services, Regulatory Compliance Services

AI in Clinical Trials Market Size and growth rate 2025 to 2029: Graph

AI In Clinical Trials Market Size 2025 And Growth Rate

The AI in clinical trials market size has grown exponentially in recent years. It will grow from $6.57 billion in 2024 to $9.21 billion in 2025 at a compound annual growth rate (CAGR) of 40.2%. The growth in the historic period can be attributed to data accumulation in healthcare, computing power advancements, FDA support for AI, rise of wearable devices, early AI algorithms development

AI In Clinical Trials Market Growth Forecast

The AI in clinical trials market size is expected to see exponential growth in the next few years. It will grow to $38.7 billion in 2029 at a compound annual growth rate (CAGR) of 43.2%. The growth in the forecast period can be attributed to real-world data integration, ai-powered patient recruitment, AI-driven biomarker identification, AI-driven trial design optimization, continuous monitoring technology. Major trends in the forecast period include federated learning approaches, AI in adaptive trials, AI-supported outcome prediction, ai-driven drug development, ai-powered drug repurposing.

Book your 30 minutes free consultation with our research experts

AI In Clinical Trials Market Driver: AI in Clinical Trials Market Surges With The Escalating Incidence Of Chronic And Infectious Diseases

Rising incidences of chronic and infectious diseases are expected to propel the growth of the AI in clinical trials market going forward. Chronic disease refers to a form of illness that lasts for three months or more and can deteriorate with time. Artificial intelligence in clinical trials is helpful to develop various drugs for treating chronic diseases. For instance, in June 2022, according to the data published by the Macmillan Cancer Support, a UK-based cancer charity, the number of people living with cancer reached 3 million in 2022 and is projected to rise to nearly 3.5 million by 2025 and 4 million by 2030 in the UK. Additionally, in August 2024, according to the data published by the UK Health Security Agency, a UK-based executive agency, in England, the UK Health Security Agency (UKHSA) reported 368 measles cases in 2023, marking a nearly sevenfold increase from the 53 cases reported in 2022, with the West Midlands and London accounting for 44% and 33% of the cases, respectively. Therefore, the rising incidences of chronic and infectious diseases are driving the growth of the AI in the clinical trials market.

AI In Clinical Trials Market Driver: Growth In AI Clinical Trials Market Propelled By The Surging Pharmaceutical Industry

The growing pharmaceutical industry is expected to propel the growth of AI in the clinical trials market going forward. The pharmaceutical industry is a sector that involves the discovery, development, and production of drugs and medicines by both governmental and private entities. The pharmaceutical industry uses artificial intelligence (AI) in clinical trials to enhance efficiency, accelerate drug development, and improve decision-making processes. AI technologies analyze large datasets, predict patient responses, identify suitable participants, and optimize trial protocols, leading to more cost-effective and streamlined clinical trials. For instance, in June 2023, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a European trade association representing the pharmaceutical industry, the total pharmaceutical production in Europe accounted for $384,200 million (€340,000 million) in 2022, with an increase of approximately 4.95% from 366,267 million (€323,950 million) in 2021. Therefore, the growing pharmaceutical industry is driving the growth of AI in the clinical trials market.

Global AI In Clinical Trials Market Major Players

Major companies operating in the AI in clinical trials market include Intel, The International Business Machines Corporation (IBM), Koninklijke Philips N.V., ConcertAI, Samaa Technologies, Owkin Inc., Numerate, Neuroute, AiCure, Ardigen, Unlearn AI, PathAI, Exscentia, Aitia Infotech Pvt Ltd., Euretos, VeriSIM Life, Envisagenics, NURITAs, BioSymetrics, BioAge Labs Inc, Trials.Ai, Pharmaseal, Caylx, IQVIA

Global AI In Clinical Trials Market Trend: Lantern Pharma Unveils Radr AI And ML Platform, Elevating AI in Clinical Trials For Accelerated Medication Discovery

Technological advancements are a key trend gaining popularity in the AI in clinical trials market. Companies operating in the AI in clinical trials market are adopting new technologies to sustain their position in the market. For instance, in February 2023, Lantern Pharma, a US-based clinical-stage oncology company introduced its unique RADR artificial intelligence (‘AI’) and machine learning (‘ML’) platform to revolutionize the expense, speed, and timeframe of oncology medication discovery and development. These RADR developments would concentrate on additional cutting-edge AI and ML methods to create antibody-drug conjugates (ADCs), which are highly targeted antibodies for the treatment of cancer that are connected to effective anti-tumor small molecules.

Global AI In Clinical Trials Market Trend: Strategic Partnerships Harness AI To Accelerate Patient Recruitment And Enhance Workflow Efficiencies

Major companies operating in the AI in clinical trials market are adopting a strategic partnership approach to deliver research tools and workflow efficiencies that result in improved timelines and increased patient recruitment. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. For instance, in February 2023, a US-based pharmaceutical commercial company partnered with Haystack Health, a US-based software development company. With this partnership, they aim to leverage AI and Natural Language Processing (NLP) to speed up clinical trials, improve patient recruitment, and reduce the screen failure rate through the use of clinical AI and pre-screening services, which can be costly in terms of time and money.

AI In Clinical Trials Market Merger And Acquisition: Beckman Coulter Diagnostics Strengthens Portfolio With Acquisition Of StoCastic LLC In The Ai Healthcare Software Space

In October 2022, Beckman Coulter Diagnostics, a US-based clinical diagnostics company acquired StoCastic LLC. for an undisclosed amount. This acquisition would aid evidence-based CDS and Beckman Coulter Diagnostics biomarkers to create enhanced decision-support insights. This would enable clinicians to make informed decisions faster and further improve patient outcomes. StoCastic LLC is a US-based artificial intelligence business that develops healthcare software.

Regional Outlook For The Global AI In Clinical Trials Market

North America was the largest region in the AI in clinical trials market in 2024. The regions covered in the AI in clinical trials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the AI in clinical trials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the AI In Clinical Trials Market?

The AI in clinical trials market consists of revenues earned by entities by providing AI software solutions and platforms designed to assist in various aspects of clinical trials, such as trial design, patient recruitment, data collection, monitoring, and analysis, data analytics and insights, predictive modeling and simulation, regulatory compliance, and safety monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The AI in clinical trials also includes sales of computer vision technology, cognitive computing, and machine translation technologies which are used in providing clinical trials. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the AI In Clinical Trials Industry?

The AI in clinical trials market research report is one of a series of new reports from The Business Research Company that provides AI in clinical trials market statistics, including AI in clinical trials industry global market size, regional shares, competitors with AI in clinical trials market share, detailed AI in clinical trials market segments, market trends, and opportunities, and any further data you may need to thrive in the AI in clinical trials industry. This AI in clinical trials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

AI in Clinical Trials Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$9.21 billion
Revenue Forecast In 2034	$38.7 billion
Growth Rate	CAGR of 43.2% from 2024 to 2033
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Offering: Software, Services 2) By Process: Trial Design, Patient Selection, Site Selection, Patient Monitoring 3) By Technology: Machine Learning, Deep Learning, Supervised Learning, Other Technologies 4) By Application: Oncology, Neurological Diseases And Condition, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases, Immunology Diseases, Other Applications 5) By End-User: Pharmaceuticals And Biotechnology Companies, Contract Research Organizations, Other End-Users Subsegments: 1) By Software: Clinical Trial Management Systems (CTMS), Data Analytics Software, Predictive Analytics Tools, Patient Recruitment And Retention Software, Real-World Evidence Platforms 2) By Services: Consulting Services, Data Management And Analysis Services, Training And Support Services, Regulatory Compliance Services
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Intel, The International Business Machines Corporation (IBM), Koninklijke Philips N.V., ConcertAI, Samaa Technologies, Owkin Inc., Numerate, Neuroute, AiCure, Ardigen, Unlearn AI, PathAI, Exscentia, Aitia Infotech Pvt Ltd., Euretos, VeriSIM Life, Envisagenics, NURITAs, BioSymetrics, BioAge Labs Inc, Trials.Ai, Pharmaseal, Caylx, IQVIA
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. AI In Clinical Trials Market Characteristics

3. AI In Clinical Trials Market Trends And Strategies

4. AI In Clinical Trials Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global AI In Clinical Trials Growth Analysis And Strategic Analysis Framework

5.1. Global AI In Clinical Trials PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global AI In Clinical Trials Market Growth Rate Analysis

5.4. Global AI In Clinical Trials Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global AI In Clinical Trials Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global AI In Clinical Trials Total Addressable Market (TAM)

6. AI In Clinical Trials Market Segmentation

6.1. Global AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Software

Services

6.2. Global AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Trial Design

Patient Selection

Site Selection

Patient Monitoring

6.3. Global AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Machine Learning

Deep Learning

Supervised Learning

Other Technologies

6.4. Global AI In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oncology

Neurological Diseases And Condition

Cardiovascular Diseases

Metabolic Diseases

Infectious Diseases

Immunology Diseases

Other Applications

6.5. Global AI In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pharmaceuticals And Biotechnology Companies

Contract Research Organizations

Other End-Users

6.6. Global AI In Clinical Trials Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Clinical Trial Management Systems (CTMS)

Data Analytics Software

Predictive Analytics Tools

Patient Recruitment And Retention Software

Real-World Evidence Platforms

6.7. Global AI In Clinical Trials Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Consulting Services

Data Management And Analysis Services

Training And Support Services

Regulatory Compliance Services

7. AI In Clinical Trials Market Regional And Country Analysis

7.1. Global AI In Clinical Trials Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global AI In Clinical Trials Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific AI In Clinical Trials Market

8.1. Asia-Pacific AI In Clinical Trials Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China AI In Clinical Trials Market

9.1. China AI In Clinical Trials Market Overview

9.2. China AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India AI In Clinical Trials Market

10.1. India AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan AI In Clinical Trials Market

11.1. Japan AI In Clinical Trials Market Overview

11.2. Japan AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia AI In Clinical Trials Market

12.1. Australia AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia AI In Clinical Trials Market

13.1. Indonesia AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea AI In Clinical Trials Market

14.1. South Korea AI In Clinical Trials Market Overview

14.2. South Korea AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe AI In Clinical Trials Market

15.1. Western Europe AI In Clinical Trials Market Overview

15.2. Western Europe AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK AI In Clinical Trials Market

16.1. UK AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany AI In Clinical Trials Market

17.1. Germany AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France AI In Clinical Trials Market

18.1. France AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy AI In Clinical Trials Market

19.1. Italy AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain AI In Clinical Trials Market

20.1. Spain AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe AI In Clinical Trials Market

21.1. Eastern Europe AI In Clinical Trials Market Overview

21.2. Eastern Europe AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia AI In Clinical Trials Market

22.1. Russia AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America AI In Clinical Trials Market

23.1. North America AI In Clinical Trials Market Overview

23.2. North America AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA AI In Clinical Trials Market

24.1. USA AI In Clinical Trials Market Overview

24.2. USA AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada AI In Clinical Trials Market

25.1. Canada AI In Clinical Trials Market Overview

25.2. Canada AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America AI In Clinical Trials Market

26.1. South America AI In Clinical Trials Market Overview

26.2. South America AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil AI In Clinical Trials Market

27.1. Brazil AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East AI In Clinical Trials Market

28.1. Middle East AI In Clinical Trials Market Overview

28.2. Middle East AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa AI In Clinical Trials Market

29.1. Africa AI In Clinical Trials Market Overview

29.2. Africa AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. AI In Clinical Trials Market Competitive Landscape And Company Profiles

30.1. AI In Clinical Trials Market Competitive Landscape

30.2. AI In Clinical Trials Market Company Profiles

30.2.1. Intel Overview, Products and Services, Strategy and Financial Analysis

30.2.2. The International Business Machines Corporation (IBM) Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. ConcertAI Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Samaa Technologies Overview, Products and Services, Strategy and Financial Analysis

31. AI In Clinical Trials Market Other Major And Innovative Companies

31.1. Owkin Inc.

31.2. Numerate

31.3. Neuroute

31.4. AiCure

31.5. Ardigen

31.6. Unlearn AI

31.7. PathAI

31.8. Exscentia

31.9. Aitia Infotech Pvt Ltd.

31.10. Euretos

31.11. VeriSIM Life

31.12. Envisagenics

31.13. NURITAs

31.14. BioSymetrics

31.15. BioAge Labs Inc

32. Global AI In Clinical Trials Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The AI In Clinical Trials Market

34. Recent Developments In The AI In Clinical Trials Market

35. AI In Clinical Trials Market High Potential Countries, Segments and Strategies

35.1 AI In Clinical Trials Market In 2029 - Countries Offering Most New Opportunities

35.2 AI In Clinical Trials Market In 2029 - Segments Offering Most New Opportunities

35.3 AI In Clinical Trials Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global AI In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global AI In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global AI In Clinical Trials Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global AI In Clinical Trials Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global AI In Clinical Trials Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global AI In Clinical Trials Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Intel Financial Performance

Table 79: The International Business Machines Corporation (IBM) Financial Performance

Table 80: Koninklijke Philips N.V. Financial Performance

Table 81: ConcertAI Financial Performance

Table 82: Samaa Technologies Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global AI In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global AI In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global AI In Clinical Trials Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global AI In Clinical Trials Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global AI In Clinical Trials Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global AI In Clinical Trials Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Intel Financial Performance

Figure 79: The International Business Machines Corporation (IBM) Financial Performance

Figure 80: Koninklijke Philips N.V. Financial Performance

Figure 81: ConcertAI Financial Performance

Figure 82: Samaa Technologies Financial Performance

Global Cybersecurity Services Market Opportunities And Strategies – Forecast To 2030 – Includes Cybersecurity Services Market Demand

Opportunities And Strategies Analysis For The Supply Chain Management Software Market – Includes Supply Chain Management Software Market Overview

Global Internet Of Things (IoT) Market Opportunities And Strategies – Forecast To 2030 – Includes Internet Of Things (IoT) Market Size

Global Ambulatory Surgical Centers IT Services Market 2022 – Market Opportunities And Strategies

The Business Research Company offers the open source intelligence market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the projection mapping market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the soc as a service market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the employment screening services market research report 2022 with industry size, share, segments and market growth

Personal Care Shower And Bath Global Market Report 2025 – By Product Type (Shower Cream or Gel, Bar Soap, Body Wash, Shower Oil, Bath Additives, Other Product Types), By Form (Solid, Gel and Jellies, Liquid, Other forms), By Distribution Channel (Supermarkets and Hypermarkets, Convenience Stores, Online Retail Stores, Other Distribution Channels), By End-Users (Men, Women) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Luxury Hair Care Products Global Market Report 2025 – By Product Type (Shampoos, Conditioners, Hair Coloring Products, Hair Styling Products, Hair Oil, Other Product Types), By Distribution Channel (Supermarkets and Hypermarkets, Departmental Stores, Specialty Stores, E-commerce, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Natural Skin Care Products Global Market Report 2025 – By Product (Facial Care, Body Care), By Type (Mass, Premium), By Distribution Channel (Direct Selling, Other Distribution Channels), By End Use (Men, Women, Children) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Natural Hair Care Products Global Market Report 2025 – By Product Type (Shampoos, Conditioners, Oils And Serum, Gel And Wax, Hair Color, Other Product Types), By Gender (Men, Women, Other Genders), By Price Category (High Or Premium, Medium, Low), By Distribution Channel (Offline, Online) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Organic Skincare Global Market Report 2025 – By Type (Facial Care, Body Care, Other Types), By Gender (Male, Female), By Distribution Channel (Supermarkets or Hypermarket, Convenience Stores, Specialist Stores, Online Retail Stores, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Hair Preparations Global Market Report 2025 – By Type (Hair Spray, Conditioner, Shampoo, Hair Oil, Hair Color, Other Types), By Gender (Male, Female, Unisex), By Based On Type (Organic, Chemical), By Distribution Channel (Hypermarkets/Supermarkets, Specialty Stores, Online Stores, Convenience Stores, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Personal Care Ingredients Global Market Report 2025 – By Ingredients (Emollients, Surfactants, Emulsifiers, Rheology Modifiers, Conditioning Polymers, Other Ingredients), By Source (Natural Ingredients, Synthetic Ingredients), By Application (Skin Care, Hair Care, Oral Care, Cosmetics, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Retail And Wholesale Global Market Report 2025 – By Type (Retail, Wholesale), By Ownership (Retail Chain/Wholesale Chain, Independent Retailer/Independent Wholesalers), By Price Range (Premium, Mid Range, Economy), By Distribution Channel (Supermarkets/Hypermarkets, Convienience Stores, Department Stores, Specialty Stores, Online, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the AI in Clinical Trials market?

How will the AI in Clinical Trials market drivers and restraints affect the market dynamics? What forces will shape the AI in Clinical Trials industry going forward?

The AI in Clinical Trials market major growth driver - AI in Clinical Trials Market Surges With The Escalating Incidence Of Chronic And Infectious Diseases. For further insights on the AI in Clinical Trials market, request a sample here

What is the forecast market size or the forecast market value of the AI in Clinical Trials market?

The AI in Clinical Trials market size has grown strongly in recent years. The AI in clinical trials market size has grown exponentially in recent years. It will grow from $6.57 billion in 2024 to $9.21 billion in 2025 at a compound annual growth rate (CAGR) of 40.2%. The growth in the historic period can be attributed to data accumulation in healthcare, computing power advancements, FDA support for AI, rise of wearable devices, early AI algorithms development The AI in clinical trials market size is expected to see exponential growth in the next few years. It will grow to $38.7 billion in 2029 at a compound annual growth rate (CAGR) of 43.2%. The growth in the forecast period can be attributed to real-world data integration, ai-powered patient recruitment, AI-driven biomarker identification, AI-driven trial design optimization, continuous monitoring technology. Major trends in the forecast period include federated learning approaches, AI in adaptive trials, AI-supported outcome prediction, ai-driven drug development, ai-powered drug repurposing. For further insights on the AI in Clinical Trials market, request a sample here

How is the AI in Clinical Trials market segmented?

The AI in clinical trials market covered in this report is segmented –
1) By Offering: Software, Services
2) By Process: Trial Design, Patient Selection, Site Selection, Patient Monitoring
3) By Technology: Machine Learning, Deep Learning, Supervised Learning, Other Technologies
4) By Application: Oncology, Neurological Diseases And Condition, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases, Immunology Diseases, Other Applications
5) By End-User: Pharmaceuticals And Biotechnology Companies, Contract Research Organizations, Other End-Users Subsegments:
1) By Software: Clinical Trial Management Systems (CTMS), Data Analytics Software, Predictive Analytics Tools, Patient Recruitment And Retention Software, Real-World Evidence Platforms
2) By Services: Consulting Services, Data Management And Analysis Services, Training And Support Services, Regulatory Compliance Services For further insights on the AI in Clinical Trials market, request a sample here

Which region has the largest share of the AI in Clinical Trials market? What are the other regions covered in the report?

North America was the largest region in the AI in clinical trials market in 2024. The regions covered in the AI in clinical trials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the AI in Clinical Trials market, request a sample here.

Who are the major players in the AI in Clinical Trials market?

What are the key trends in the AI in Clinical Trials market?

Major trends in the AI in Clinical Trials market include Lantern Pharma Unveils Radr AI And ML Platform, Elevating AI in Clinical Trials For Accelerated Medication Discovery. For further insights on the AI in Clinical Trials market, request a sample here.

What are the major opportunities in the AI in Clinical Trials market? What are the strategies for the AI in Clinical Trials market?

For detailed insights on the major opportunities and strategies in the AI in Clinical Trials market, request a sample here.

How does the AI in Clinical Trials market relate to the overall economy and other similar markets?

For detailed insights on AI in Clinical Trials's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the AI in Clinical Trials industry?

For detailed insights on the mergers and acquisitions in the AI in Clinical Trials industry, request a sample here.

What are the key dynamics influencing the AI in Clinical Trials market growth? SWOT analysis of the AI in Clinical Trials market.

For detailed insights on the key dynamics influencing the AI in Clinical Trials market growth and SWOT analysis of the AI in Clinical Trials industry, request a sample here.